It has been proposed that PELI2 could promote the growth and metastasis of gastric cancer cells by regulating vascular endothelial growth factor C, considered as a sensitive predictive tool for lymphatic metastasis in gastric cancer (Zhang et al. 2019). This evidence concerns the gene VEGFC and gastric cancer.